Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 23, 2026 16:01 ET | Source: Galapagos NV

Galapagos rapporteert resultaten over het gehele jaar 2025 en geeft een business update over het vierde kwartaal

Strategische heroriëntatie positioneert Galapagos voor waardecreatie op lange termijn Sterke positie van €3,0 miljard aan kasmiddelen en financiële investeringen eind 2025 en de blijvende samenwerking...
February 19, 2026 16:01 ET | Source: Galapagos NV

Galapagos verwelkomt Dr. Paulo Fontoura in haar Raad van Bestuur

Dr. Fontoura brengt uitgebreide ervaring in wereldwijd leiderschap, klinische ontwikkeling en operationele aansturing mee naar de Raad van Bestuur Mechelen, België; 19 februari 2026, 22:01 CET —...
February 19, 2026 16:01 ET | Source: Galapagos NV

Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors

Dr. Fontoura brings extensive global leadership, clinical development, and operational experience to the Board Mechelen, Belgium; February 19, 2026, 22:01 CET — Galapagos NV (Euronext & NASDAQ:...
February 18, 2026 10:28 ET | Source: Research and Markets

JAK Inhibitors Competitive Landscape Report 2026: Comprehensive Insights on 40+ Companies and 45+ Drugs by Company, Product Type, Development Stage, Administration Route, Molecule Type

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "JAK Inhibitors - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report delivers a detailed analysis of over...
February 16, 2026 16:01 ET | Source: Galapagos NV

Galapagos ontvangt transparantieverklaring van Bank of America

Mechelen, België; 16 februari 2026, 22:01 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GLPG) heeft een transparantieverklaring ontvangen van Bank of America. ...
February 16, 2026 16:01 ET | Source: Galapagos NV

Galapagos Receives Transparency Notification from Bank of America

Mechelen, Belgium; February 16, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Bank of America. Pursuant to Belgian...
February 10, 2026 16:01 ET | Source: Galapagos NV

Galapagos ontvangt transparantieverklaringen van Bank of America

Mechelen, België; 10 februari 2026, 22:01 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GLPG) heeft transparantieverklaringen ontvangen van Bank of America. Overeenkomstig...
February 10, 2026 16:01 ET | Source: Galapagos NV

Galapagos Receives Transparency Notifications from Bank of America

Mechelen, Belgium; February 10, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America. Pursuant to Belgian...
January 19, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Tenosynovial Giant Cell Tumors Market to Show Significant Growth by 2034 as CSF1R-Targeted Therapies Drive the Next Wave | DelveInsight

New York, USA, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Tenosynovial Giant Cell Tumors Market to Show Significant Growth by 2034 as CSF1R-Targeted Therapies Drive the Next Wave | DelveInsight The...
January 13, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

New York, USA, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics –...